PCN42 COST EFFECTIVENESS OF FULVESTRANT AS AN ADDITIONAL ENDOCRINE STEP IN THE TREATMENT SEQUENCE FOR HORMONE RESPONSIVE ADVANCED BREAST CANCER
Nov 1, 2006, 00:00 AM
10.1016/S1098-3015(10)63472-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)63472-9/fulltext
Section Title :
Section Order :
323
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63472-9&doi=10.1016/S1098-3015(10)63472-9